Acarix AB’s Annual Report 2025
Acarix, a global leader in AI and advanced acoustic-based cardiac diagnostics, today announces that the Annual Report for 2025 is avail...
ACARIX PRESENTS ABSTRACT AT ACC.26 HIGHLIGHTING CADSCOR® SYSTEM’S DIAGNOSTIC UTILITY COMPARED TO STANDARD STRESS TESTS IN CHEST PAIN PATIENTS
Findings demonstrate high NPV, care time savings of up to 40 hours, and cost reductions exceeding $100,000 per inpatient case, reinforc...
Acarix Publishes Year-End Report 2025
Malmö, Sweden – Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2025 year-end finan...
Acarix Announces New Distribution Partner in Saudi Arabia for the CADScor System
Malmö, Sweden – Acarix AB (Nasdaq Stockholm: ACARIX), a medical device company advancing noninvasive, AI enabled diagnostics...
Acarix Receives EU MDR Certification for the CADScor®System
Malmö, Sweden – Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announced that its CADScor Sys...
ACARIX CARRIES OUT A DIRECTED SHARE ISSUE OF APPROX. SEK 33.4 MILLION
The Board of Directors of Acarix AB (publ) ("Acarix" or the "Company") has today resolved to carry out a directed share issue of maximu...
Invitation to presentation of Acarix´s third quarter 2025 report
Acarix third quarter result is now released and we invite investors, analysts, and media representatives to join the recorded webcast p...
Acarix Publishes Interim Report, Third quarter 2025
Malmö, Sweden – Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial ...
Announcement from the general meeting in Acarix AB
The extraordinary general meeting 2025 (the "EGM") of Acarix AB ("Acarix" or the "Company") was held today on 27 October 2025 and the f...
Acarix AB changes Certified Adviser to Tapper Partners AB
Malmö, Sweden – Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announce that the company is c...
Acarix responds to G-BA decision on reimbursement in the German market
Malmö, Sweden – Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announce that G-BA reached a n...
NOTICE OF EXTRAORDINARY GENERAL MEETING IN ACARIX AB
The shareholders in Acarix AB (publ) corp. reg. no 559009-0667 (the “Company”) are hereby convened to an extraordinary gene...